Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Align Technology, Inc. stock logo
ALGN
Align Technology
$136.52
+5.8%
$187.04
$127.70
$262.87
$9.35B1.611.58 million shs7.97 million shs
Chemed Corporation stock logo
CHE
Chemed
$418.08
+1.4%
$508.86
$408.42
$623.60
$6.03B0.5161,266 shs278,714 shs
Encompass Health Corporation stock logo
EHC
Encompass Health
$108.67
-1.3%
$116.88
$82.74
$123.13
$11.10B0.861.03 million shs1.27 million shs
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$239.15
0.0%
$224.19
$187.43
$352.33
$17.20B1.05841,329 shs632,899 shs
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Align Technology, Inc. stock logo
ALGN
Align Technology
+5.82%-33.59%-30.69%-24.08%-41.12%
Chemed Corporation stock logo
CHE
Chemed
+1.24%-10.87%-11.34%-27.40%-26.67%
Encompass Health Corporation stock logo
EHC
Encompass Health
-1.29%+1.06%-8.62%-6.90%+16.92%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
+0.18%-9.18%+8.04%+13.20%-21.89%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Align Technology, Inc. stock logo
ALGN
Align Technology
4.925 of 5 stars
4.34.00.03.82.23.32.5
Chemed Corporation stock logo
CHE
Chemed
4.9718 of 5 stars
3.45.03.34.92.32.52.5
Encompass Health Corporation stock logo
EHC
Encompass Health
4.8783 of 5 stars
2.65.01.75.03.42.52.5
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
4.6151 of 5 stars
3.43.01.73.23.31.71.9
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Align Technology, Inc. stock logo
ALGN
Align Technology
2.60
Moderate Buy$215.0057.49% Upside
Chemed Corporation stock logo
CHE
Chemed
2.75
Moderate Buy$579.7538.67% Upside
Encompass Health Corporation stock logo
EHC
Encompass Health
3.14
Buy$131.5021.01% Upside
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
2.89
Moderate Buy$320.7134.11% Upside

Current Analyst Ratings Breakdown

Latest WST, CHE, EHC, and ALGN Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/31/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Set Price Target$210.00
7/31/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$246.00 ➝ $199.00
7/31/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$275.00 ➝ $200.00
7/31/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$250.00 ➝ $190.00
7/31/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Equal Weight$249.00 ➝ $154.00
7/31/2025
Chemed Corporation stock logo
CHE
Chemed
Royal Bank Of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$640.00 ➝ $589.00
7/31/2025
Chemed Corporation stock logo
CHE
Chemed
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$650.00 ➝ $580.00
7/25/2025
Chemed Corporation stock logo
CHE
Chemed
Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageHold$500.00
7/25/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$285.00 ➝ $320.00
7/25/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$275.00 ➝ $350.00
7/9/2025
Align Technology, Inc. stock logo
ALGN
Align Technology
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$200.00 ➝ $220.00
(Data available from 8/2/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Align Technology, Inc. stock logo
ALGN
Align Technology
$4.00B2.47$9.51 per share14.35$53.98 per share2.53
Chemed Corporation stock logo
CHE
Chemed
$2.51B2.43$26.08 per share16.03$81.92 per share5.10
Encompass Health Corporation stock logo
EHC
Encompass Health
$5.37B2.04$7.46 per share14.57$27.72 per share3.92
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$2.89B5.94$9.01 per share26.55$40.73 per share5.87
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Align Technology, Inc. stock logo
ALGN
Align Technology
$421.36M$5.9323.0215.251.3611.04%13.36%8.32%N/A
Chemed Corporation stock logo
CHE
Chemed
$302M$19.4521.5017.942.2111.56%25.83%17.77%N/A
Encompass Health Corporation stock logo
EHC
Encompass Health
$455.70M$4.8422.4520.582.238.97%17.63%7.33%8/4/2025 (Estimated)
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$492.70M$6.6835.8030.434.2316.48%18.43%13.67%N/A

Latest WST, CHE, EHC, and ALGN Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/4/2025Q2 2025
Encompass Health Corporation stock logo
EHC
Encompass Health
$1.20N/AN/AN/A$1.43 billionN/A
7/30/2025Q2 2025
Align Technology, Inc. stock logo
ALGN
Align Technology
$2.57$2.49-$0.08$1.72$1.06 billion$1.01 billion
7/29/2025Q2 2025
Chemed Corporation stock logo
CHE
Chemed
$6.02$4.27-$1.75$3.57$650.60 million$618.80 million
7/24/2025Q2 2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$1.51$1.84+$0.33$1.82$725.11 million$766.50 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Align Technology, Inc. stock logo
ALGN
Align Technology
N/AN/AN/AN/AN/A
Chemed Corporation stock logo
CHE
Chemed
$2.000.48%N/A10.28%16 Years
Encompass Health Corporation stock logo
EHC
Encompass Health
$0.680.63%N/A14.05%2 Years
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
$0.840.35%N/A12.57%N/A

Latest WST, CHE, EHC, and ALGN Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/24/2025
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
quarterly$0.220.39%11/12/202511/12/202511/19/2025
7/24/2025
Encompass Health Corporation stock logo
EHC
Encompass Health
quarterly$0.190.7%10/1/202510/1/202510/15/2025
5/20/2025
Chemed Corporation stock logo
CHE
Chemed
quarterly$0.500.3%5/29/20255/29/20256/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Align Technology, Inc. stock logo
ALGN
Align Technology
N/A
1.23
1.08
Chemed Corporation stock logo
CHE
Chemed
N/A
1.86
1.70
Encompass Health Corporation stock logo
EHC
Encompass Health
0.81
1.06
1.06
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.07
2.78
2.08

Institutional Ownership

CompanyInstitutional Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
88.43%
Chemed Corporation stock logo
CHE
Chemed
95.85%
Encompass Health Corporation stock logo
EHC
Encompass Health
97.25%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
93.90%

Insider Ownership

CompanyInsider Ownership
Align Technology, Inc. stock logo
ALGN
Align Technology
0.66%
Chemed Corporation stock logo
CHE
Chemed
3.29%
Encompass Health Corporation stock logo
EHC
Encompass Health
2.00%
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
0.53%
CompanyEmployeesShares OutstandingFree FloatOptionable
Align Technology, Inc. stock logo
ALGN
Align Technology
20,94572.49 million72.01 millionOptionable
Chemed Corporation stock logo
CHE
Chemed
15,69514.63 million14.15 millionOptionable
Encompass Health Corporation stock logo
EHC
Encompass Health
40,000100.80 million98.78 millionOptionable
West Pharmaceutical Services, Inc. stock logo
WST
West Pharmaceutical Services
10,60071.91 million71.53 millionOptionable

Recent News About These Companies

West Pharmaceutical: Q2 Earnings Suggest Recovery
Best Momentum Stocks to Buy for July 28th
William Blair Has Positive Estimate for WST Q3 Earnings

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Align Technology stock logo

Align Technology NASDAQ:ALGN

$136.52 +7.51 (+5.82%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$137.35 +0.83 (+0.61%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Chemed stock logo

Chemed NYSE:CHE

$418.08 +5.78 (+1.40%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$438.00 +19.93 (+4.77%)
As of 08/1/2025 04:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.

Encompass Health stock logo

Encompass Health NYSE:EHC

$108.67 -1.44 (-1.31%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$108.34 -0.33 (-0.30%)
As of 08/1/2025 05:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

West Pharmaceutical Services stock logo

West Pharmaceutical Services NYSE:WST

$239.15 -0.11 (-0.05%)
Closing price 08/1/2025 03:59 PM Eastern
Extended Trading
$236.46 -2.69 (-1.12%)
As of 08/1/2025 06:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.